Henry Schein, Inc.· HSIC

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

• 

  Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?

  Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

  Sep 3, 2026
• 

  Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why

  Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.

  Sep 3, 2026
• 

  Is Henry Schein (HSIC) Stock Undervalued Right Now?

  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  Sep 2, 2026
• 

  Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

  Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  Sep 2, 2026
• 

  505,999 Shares in Henry Schein, Inc. $HSIC Purchased by Bank of New York Mellon Corp

  Bank of New York Mellon Corp purchased a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 505,999 shares of the company's stock, valued at approximately $42,261,000. Bank of New York

  Aug 28, 2026

• BT

  Henry Schein price target raised to $110 from $100 at BTIG

  BTIG· David Larsen· $110.00
  Aug 19, 2026
• BA

  Henry Schein price target raised to $104 from $97 at Barrington

  Barrington· Michael Petusky· $104.00
  Aug 5, 2026
• UB

  Henry Schein price target raised to $94 from $89 at UBS

  UBS· Kevin Caliendo· $94.00
  Aug 5, 2026
• BC

  Henry Schein initiated with a Market Perform at BMO Capital

  BMO Capital· Vik Chopra· $85.00
  Jul 8, 2026
• UB

  Henry Schein price target lowered to $85 from $87 at UBS

  UBS· Kevin Caliendo· $85.00
  May 6, 2026